Partnership Opportunities

Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the meeting or topic.

Want to Become the Go-To Provider of Assay, Screening and Early Discovery Solutions for Drug Developers?

The RNA targeting field is rapidly evolving with drug developers around the world racing to make best-in-class RNA targeting small molecule therapeutics. To achieve this, leading experts are looking to advance their early discovery, assay and screening strategies, by working with service providers who have capabilities in assay development, genomic profiling, bioinformatics, sequencing, bioanalysis, NMR and computational tools.

This summit is your opportunity to communicate exciting progress to the RNA field, generate leads, and better understand what tools and services the market wants and needs. You can rely on our ability to advise and deliver the right opportunities for you.

If you offer relevant services and want to maximize your company’s exposure, contact us today to discuss your bespoke commercial package at the RNA Assay Development & Screening Summit.

Partner With This Summit To:

1 (6)
2 (1)
3
4
Icon 5

Benefit from Market Intelligence

Hear how and where pharmaceutical companies are looking for services and solutions to facilitate their RNA targeted drug discovery and match your solutions accordingly

Icon 2

Meet & Network In-Person with Industry Pioneers

With a room full of drug developers looking to develop more robust and sensitive assay and screening strategies, meet prospective clients during speed networking breaks and informal networking receptions to fuel commercial opportunities

Icon 1

Position Yourself as an Industry Expert

With the growing landscape of RNA targeting biotech companies, this meeting is a dedicated platform to put your independent expertise in front of the key decision-makers in the field

Icon 3

Raise Brand Awareness & Generate Commercial Collaborations

Benefit from pre and post conference exposure to our key opinion leaders and make sure you connect with the hottest prospects

Hear What our Expert Speakers Have to Say:

"In the nascent RNA-targeting small molecule space, the RNA Assay Development & Screening Summit provides an important opportunity for players across the small molecule space to compare notes on what’s working and not in the early discovery phase."


Chuhern Hwang, Co-Founder & Head of Drug Discovery, Wayfinder Biosciences

"I see great value in this meeting, particularly as an opportunity to share our experiences in the emerging field of RNA targeting by small molecules. This area of therapeutics is still very explorative, so it is fun meeting the people, who have the courage to build new expertise."

Kasia Drzewicka, Senior Scientist, Molecure

“It’s a great forum to meet academic and industry leaders in the RNA field and an opportunity to network and share experiences, challenges, and new developments.”

Balajee Somalinga, Director, RNA Biology, CHDI Management

“It’s an important opportunity to observe your peers work and approaches. In such a young field, sharing ideas and experience is essential to moving the field forward.”

Benjamin Brigham, Senior Scientist, Atavistik Bio

“This meeting will highlight contemporary methods from scientists of diverse backgrounds and expertise to study and target RNA biology.”

Ku-Lung (Ken) Hsu, Associate Professor, University of Texas at Austin

“The Meeting will be a great opportunity to discuss our needs and challenges in RNA-oriented research. I hope to share ideas and find new scientific friendships and collaborations.”

Martyna Nowacka, Senior Scientist, Molecure

“This conference will be a highly valuable platform to share solutions and challenges to further advance the field of RNA as drug targets for small molecules”

Stefan Schiesser, Director, Medicinal Chemistry, AstraZeneca